Surgery and postoperative radiation therapy in stage II endometrial carcinoma

被引:23
作者
Calvin, DP
Connell, PP
Rotmensch, J
Waggoner, S
Mundt, AJ
机构
[1] Univ Chicago Hosp, Dept Radiat & Cellular Oncol, Gynecol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago Hosp, Dept Obstet & Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1999年 / 22卷 / 04期
关键词
endometrial carcinoma; stage II; postoperative radiation therapy;
D O I
10.1097/00000421-199908000-00003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The traditional approach to patients with stage II endometrial carcinoma is preoperative radiation therapy (RT) followed by surgery. Currently, many patients are treated with primary surgery and postoperative RT. We retrospectively reviewed the outcome of 44 stage II (32 IIA, 12 IIB) patients who underwent surgery and postoperative RT. Nine (20%) had microscopic cervical involvement noted before surgery, and 35 (80%) had occult involvement noted postoperatively. Postoperative RT consisted of whole pelvic RT (WPRT) (50%), vaginal brachy-therapy (VB) (18%), or both (32%). At a median follow-up of 40 months, the 5-year actuarial disease-free survival was 72.4%. Two patients (4%) had recurrence in the pelvis tone vagina, one lateral pelvis). Eighteen stage IIA patients treated with WPRT alone and eight stage IIA patients, without deep myometrial invasion (MI), were treated with VB alone, and remained controlled in the pelvis. Extrapelvic recurrences occurred in 12 patients (25%), primarily in those with deep MI and/or grade 2-3 disease. Our results suggest that patients with stage II endometrial carcinoma with microscopic or occult cervical involvement treated with surgery and postoperative RT have a favorable outcome. A high rate of pelvic control is achieved with RT tailored to the pathologic findings.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 58 条
  • [1] POSTOPERATIVE RADIATION-THERAPY FOR SURGICALLY STAGED ENDOMETRIAL CANCER - IMPACT OF TIME FACTORS (OVERALL TREATMENT TIME AND SURGERY-TO-RADIATION INTERVAL) ON OUTCOME
    AHMAD, NR
    LANCIANO, RM
    CORN, BW
    SCHULTHEISS, T
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04): : 837 - 842
  • [2] Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
  • [3] BAQUET CR, 1986, CANC BLACKS
  • [4] ENDOMETRIAL CANCER - STAGE AT DIAGNOSIS AND ASSOCIATED FACTORS IN BLACK-AND-WHITE PATIENTS
    BARRETT, RJ
    HARLAN, LC
    WESLEY, MN
    HILL, HA
    CHEN, VW
    CLAYTON, LA
    KOTZ, HL
    ELEY, W
    ROBBOY, SJ
    EDWARDS, BK
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (02) : 414 - 423
  • [5] RISK-FACTORS AND PROGNOSIS IN STAGE II ENDOMETRIAL CANCER
    BERMAN, ML
    AFRIDI, MA
    KANBOUR, AI
    BALL, HG
    [J]. GYNECOLOGIC ONCOLOGY, 1982, 14 (01) : 49 - 61
  • [6] BRUCKMAN JE, 1978, CANCER-AM CANCER SOC, V42, P1146, DOI 10.1002/1097-0142(197809)42:3<1146::AID-CNCR2820420318>3.0.CO
  • [7] 2-D
  • [8] VAGINAL STENOSIS AND SEXUAL FUNCTION FOLLOWING INTRACAVITARY RADIATION FOR THE TREATMENT OF CERVICAL AND ENDOMETRIAL CARCINOMA
    BRUNER, DW
    LANCIANO, R
    KEEGAN, M
    CORN, B
    MARTIN, E
    HANKS, GE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (04): : 825 - 830
  • [9] PREOPERATIVE OR POSTOPERATIVE BRACHYTHERAPY FOR PATIENTS WITH ENDOMETRIAL CARCINOMA STAGE-I AND STAGE-II
    CALAIS, G
    VITU, L
    DESCAMPS, P
    BODY, G
    REYNAUDBOUGNOUX, A
    LANSAC, J
    BOUGNOUX, P
    LEFLOCH, O
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (03): : 523 - 527
  • [10] ADENOCARCINOMA CORPUS ET COLLI - ANALYSIS OF DIAGNOSTIC VARIABLES
    CALKINS, AR
    STEHMAN, FB
    SUTTON, GP
    REDDY, S
    HORNBACK, NB
    EHRLICH, CE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (06): : 911 - 916